ArticleFrontiers in public health2025
Institutionalization of health impact assessment in China: status quo, challenges and perspectives.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploration of Pathways for Integrating Health into All Policies from the Perspective of Environmental Health Governance in China.China CDC weekly · 2026Article
- Assessment of China's food and nutrition policies based on healthy food environment policy index (food-EPI): focusing on governance, funding and resources, platforms for interaction.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Health Impact Assessment (HIA) is a critical tool for integrating health into public policy. While China has advanced HIA institutionalization through national legislation, a comprehensive analysis of its implementation across different levels of governance is needed. Methods: This study conducts a systematic policy analysis of national laws, subnational pilot programs, and technical guidelines to examine the development of HIA in China. The analysis focuses on institutional arrangements, drivers, and barriers identified in key regions, including Zhejiang, Sichuan, and Shanghai. Results: The analysis reveals that despite innovative subnational models such as Zhejiang's AI-powered decision-support system, national implementation remains fragmented. Key challenges include unclear institutional mandates, a critical tension between health-led and department-led assessment processes, and limited public participation. Conclusion: We conclude that sustainable HIA institutionalization in China requires not only dedicated legislation but also deeper integration with the Health in All Policies (HiAP) framework, coupled with robust mechanisms for transparency and accountability. These findings offer a roadmap for China and a comparative case for HIA development in other complex governance systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.